Quick Answer
Traws Pharma, Inc. reported Stockholders Equity of $11.57 million for the year ending 2019.
- Traws Pharma, Inc. showed an increase of +114.9% in Stockholders Equity from 2018 to 2019.
- This data is from Traws Pharma, Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2020.
- XBRL data for this metric is available from 2012 to 2019 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2011: -$138.42 million | Q2 2012: -$158.75 million | Q3 2012: -$152.63 million | Q2 2013: -$172.94 million | Q3 2013: $93.83 million | Q1 2014: $63.91 million | Q2 2014: $48.52 million | Q3 2014: $35.27 million | Q1 2015: $11.76 million | Q2 2015: $3.75 million | Q3 2015: $3.37 million | Q1 2016: $5.99 million | Q2 2016: $1.22 million | Q3 2016: $9.19 million | Q1 2017: -$3.54 million | Q2 2017: -$388.0 thousand | Q3 2017: -$6.91 million | Q1 2018: -$7.71 million | Q2 2018: $15.92 million | Q3 2018: $10.86 million | Q1 2019: -$1.54 million | Q2 2019: -$4.55 million | Q3 2019: -$6.04 million.
- Over the full 8 years of available data (2012 to 2019), Traws Pharma, Inc.'s Stockholders Equity has grown by 107.3%.
- Historical annual values: Fiscal year 2019: $11.57 million | Fiscal year 2018: $5.39 million | Fiscal year 2017: -$11.69 million | Fiscal year 2016: $4.30 million | Fiscal year 2015: $10.01 million | Fiscal year 2014: $22.75 million | Fiscal year 2013: $80.41 million | Fiscal year 2012: -$158.31 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: